Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Randomized Phase 2/3 Multi-Center Study of SM-88 in Patients With Metastatic Pancreatic Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03512756
Recruitment Status : Active, not recruiting
First Posted : May 1, 2018
Last Update Posted : June 21, 2021
Sponsor:
Information provided by (Responsible Party):
Tyme, Inc

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : December 31, 2021
Estimated Study Completion Date : December 31, 2021